Amino terminal amino acid sequence of macromomycin, a protein antitumor antibiotic. 1979

T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke

UI MeSH Term Description Entries
D009353 Zinostatin An enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic. Neocarzinostatin
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
January 1983, The Journal of biological chemistry,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
June 1977, Antimicrobial agents and chemotherapy,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
November 1991, The Journal of antibiotics,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
January 1968, The Journal of antibiotics,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
May 1978, The Journal of biological chemistry,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
October 1974, Archives of biochemistry and biophysics,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
July 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
April 1955, Biochimica et biophysica acta,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
November 1980, Molecular pharmacology,
T H Sawyer, and K Guetzow, and M O Olson, and H Busch, and A W Prestayko, and S T Crooke
March 1976, European journal of immunology,
Copied contents to your clipboard!